In the 1960s, as the United States and Soviet Union set their sights on outer space and the Moon, the United Kingdom and France embarked on an expensive joint “moonshot” of their own: Concorde, the world’s first supersonic passenger airliner.
Concorde – at the bleeding edge of 1960s and 1970s aviation technology – transported passengers in fine style across the Atlantic Ocean in a matter of three or four hours, shrinking exponentially the distance between the global cultural and financial command centers of London, Paris, and New York.
Concorde flew for British Airways and Air France for nearly 35 years. It was a glamorous technological triumph, but a commercial failure, never able to sustain the passenger numbers needed for profitability. Concorde’s first and only fatal accident, in 2000, threw its problems into sharp focus, and the supersonic liner made its final flight into London Heathrow in 2003.
There have been no civilian supersonic flights to speak of in the 19 years since.
But there are tantalizing signs this is getting ready to change – and we can all look forward to faster travel across a smaller world in the near future.
After the Concorde stopped flying, there were still people with deep pockets exploring the possibilities of supersonic flying. Aviation consultant Brian Foley has said over the past two decades that he’s heard two thoughts frequently:
“The first is that no one denies there’s a market for supersonic jets,” and “The other thing is that manufacturers keep saying it will be within 10 years.”
Billionaire Robert Bass partnered with Boeing (BA) but recently gave up on his quest to build eight to 10 supersonic business jets.
Yet two other companies are still working on their version of the supersonic jet. Boston-based Spike Aerospace and San Jose-based Exosonic Inc. are working on projects, and Atlanta-based Hermeus Corp. is working with the United States Air Force on its supersonic vision.
Trouble is, most of these firms are still on the drawing board.
But a hungry, Denver-based aviation startup is hard at work on a radical new airframe – capable of hauling up to 88 passengers at speeds in excess of Mach 2.2, or about 1,600 miles per hour. That’s more than twice as fast as a Boeing 787 Dreamliner in normal cruise.
And whereas the competition is still in the drafting phase, this company is getting ready to fly its very own demonstrator this year.
Hackers have a new favorite type of cybercrime you need to watch out for. It’s called “SIM-swapping,” and incidents have increased more than five-fold over the last year – creating a huge problem for everyday folks and major corporations alike.
With SIM-swapping, cyber thieves are able to clone your phone and gain access to all kinds of sensitive personal and financial data, even bypassing two-factor authentication.
Once inside, they can drain money from your online accounts in as little as 90 seconds.
Victims have already suffered more than $68 million in losses in roughly 1,600 hacks, according to a recent FBI report.
In today’s burgeoning digital world, thwarting cybercrimes is big business. Fortune Business Insights predicts the cyber security market will more than double by 2028 to $366 billion.
And I’ve identified a savvy leader in the field on pace to double its earnings in less than three years.
It already has over 39,000 organizations using its platform, including HP Inc. (HP), Anheuser Busch InBev SA (BUD), state agencies, and even the Boston Red Sox.
Today, I want to let you in on one of the most exciting tech stocks of the year before it even hits the markets. Already valued at around $1.6 billion, this future tech leader is set to go public through a special-purpose acquisition company...
As tech investors, we know some of the biggest, most important tech companies in the world today started out in (very) humble garages. Their visionary founders worked hard, developed their ideas and products, and then boldly put them out there for the whole world to see. They didn’t do this alone – they had early investors backing them all the way. In the case of Apple, Microsoft, and many others, those earliest investors got the chance at life-changing wealth long before retail investors did. Now one of America’s most famous angel investors thinks history could be repeating itself in garages, dorm rooms, and labs across America. He’s investing $100,000 into small businesses like these because he believes the “next” Apple and Tesla are out there. He’s on a mission to find these up-and-coming visionaries before the world does, and he wants to know: Are you in or not?
As I’ve predicted, quantum computing investment is intensifying. Last week, news broke that IBM has partnered with Quebec’s provincial government to deploy Canada’s first-ever quantum computing facility (though it’s IBM’s fifth quantum installation worldwide). The Quebec facility is expected to help advance the fields of battery development, artificial intelligence, microelectronics, and Cloud deployment. Michael’sresearch has already identified some of the top company’s investors can buy to maximize their profit potential on this mega-trend that you can read here.
When we spoke on January 25, I noted that a major drugmaker just made a huge cannabis merger. to fill out its franchise of cutting-edge medical science. Today, I'm following up to let you know about another big cannabis breakthrough - it just...
The pharmaceuticals industry has made huge strides forward in the last few years. Look at what MRNA has done. It’s allowed us to develop vaccines against the novel coronavirus in a previously unheard-of timeframe of less than one year.
Now a major pharma player has made a new acquisition a new space in order to continue diversifying their business.
Many investors might not think about cannabis when thinking about cutting-edge biotech, but that’s exactly where this Big Pharma industry leader is looking.
That’s why they recently agreed to pay some $6.7 billion for a company with a leading drug candidate that includes the use of cannabinoids.
And since we’re no ordinary investors, we know very well that overlooked opportunities like this one are often where the most impressive profits can be found.
I believe this merger shows exactly how the drug giant I have in mind for you today manages to stay on the leading edge of medical science.
The company also has a track record of successful drug partnerships including one that resulted in the breakthrough Covid vaccine I just mentioned a moment ago, as well as a new treatment pill designed to help revolutionize the fight against the global pandemic.
No wonder the company’s stock has been tripling the overall market’s returns.